Anti-Cleaved Caspase-3 抗体 [E83-77]
Anti-Cleaved Caspase-3 antibody [E83-77]
- 20ul selling size
- RabMAb
- Recombinant
- KO Validated
- 詳細を見る
4
(28 Reviews)
|
(612 Publications)
Anti-Cleaved Caspase-3 antibody [E83-77] (ab32042) is a rabbit monoclonal antibody detecting Cleaved Caspase-3 in Western Blot, ICC/IF. Suitable for Human,.
- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 610 publications
- Trusted since 2006
別名を表示する
CPP32, CASP3, Caspase-3, CASP-3, Apopain, Cysteine protease CPP32, Protein Yama, SREBP cleavage activity 1, CPP-32, SCA-1
- WB
Lab
Western blot - Anti-Cleaved Caspase-3 antibody [E83-77] (AB32042)
Lane 1 : Wild type HAP1 + DMSO for 24 hours, whole cell lysate (20 μg)
Lane 2 : Wild type HAP1 + 2uM Staurosporine (ab146588) for 24 hours, whole cell lysate (20 μg)
Lane 3 : HAP1 CASP3 KO + DMSO for 24 hours, whole cell lysate (20 μg)
Lane 4 : HAP1 CASP3 KO + 2uM Staurosporine (ab146588) for 24 hours, whole cell lysate (20 μg)
Lane 5 : HeLa + DMSO for 24 hours, whole cell lysate (20 μg)
Lane 6 : HeLa + 2uM Staurosporine (ab146588) for 24 hours, whole cell lysate (20 μg)
Lanes 1 - 6 : Merged signal (red and green). Green - ab32042 observed at 17 kDa. Red - loading control, ab130007, observed at 130 kDa.
ab32042 was shown to specifically react with CASP3 (Caspase-3) when CASP3 (Caspase-3) knockout samples were used. HAP1 wild-type and CASP3 (Caspase-3) knockout samples were subjected to SDS-PAGE. ab32042 and ab130007 (Mouse anti vinculin loading control) were incubated overnight at 4°C at 500 dilution and 1/10000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/10000 dilution for 1 hour at room temperature before imaging.
Cells were grown to confluency prior to treatment.
All lanes:
Western blot - Anti-Cleaved Caspase-3 antibody [E83-77] (ab32042)
Predicted band size: 32 kDa
false
- ICC/IF
PubMed
Immunocytochemistry/ Immunofluorescence - Anti-Cleaved Caspase-3 antibody [E83-77] (AB32042)
High-glucose induces apoptosis in human Vascular endothelial cells (VECs).
Apoptotic responses in VEC were analyzed by detection of cleaved-Caspase-3 immunofluorescence using ab32042. Cells were treated with low glucose (LG) or high glucose (HG) for 72 hours before treated with 100 ng/mL bFGF, 1 μM sp600125 (sp), or 1 μM U0126 (U) or 10 μM MnTmPyP for 1 hour. Bar = 100 μm.
Image from Zhu ZX et al., PLoS One. 2015;10(12):e0144495. Fig 7.; doi: 10.1371/journal.pone.0144495. Reproduced under the Creative Commons license http://creativecommons.org/licenses/by/4.0/
- WB
Supplier Data
Western blot - Anti-Cleaved Caspase-3 antibody [E83-77] (AB32042)
Western blot : Anti-CASP3 antibody [E83-77] (ab32042) staining at 1/500 dilution, shown in green; Mouse anti-Alpha Tubulin [DM1A] (ab7291) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab32042 was shown to bind specifically to CASP3. A band was observed at 16/28 kDa in treated wild-type HeLa cell lysates with no signal observed at this size in CASP3 knockout cell line. To generate this image, wild-type and CASP3 knockout HeLa cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-Cleaved Caspase-3 antibody [E83-77] (ab32042) at 1/500 dilution
Lane 1:
Wild-type HeLa Treated Staurosporine (2uM, 4h) cell lysate at 20 µg
Lane 2:
CASP3 knockout HeLa Treated Staurosporine (2uM, 4h) cell lysate at 20 µg
Lane 3:
Wild-type HeLa Vehicle Control Staurosporine (0uM, 4h) cell lysate, at 20 µg
Lane 4:
CASP3 knockout HeLa Vehicle Control Staurosporine (0uM, 4h) cell lysate at 20 µg
Predicted band size: 32 kDa
Observed band size: 16 kDa,28 kDa
false
- WB
Unknown
Western blot - Anti-Cleaved Caspase-3 antibody [E83-77] (AB32042)
Lanes 1 - 2:
anti Pro Caspase 3 at 1/10000 dilution
Lanes 3 - 4:
Western blot - Anti-Cleaved Caspase-3 antibody [E83-77] (ab32042) at 1/500 dilution
Lane 1:
Jurkat (human T cell leukemia cell line from peripheral blood) cell lysate
Lanes 2 and 4:
Jurkat cell lysate + Camptothecin
Lane 3:
Jurkat cell lysate
Predicted band size: 32 kDa
Observed band size: 17 kDa,30 kDa
false
- WB
Ap
Western blot - Anti-Cleaved Caspase-3 antibody [E83-77] (AB32042)
All lanes:
Western blot - Anti-Cleaved Caspase-3 antibody [E83-77] (ab32042) at 1/500 dilution
Lane 1:
HeLa Whole Cell Lysate (2 uM Staurosporine, 4Hr) at 20 µg
Lane 2:
HeLa Whole Cell Lysate (untreated) at 20 µg
Lane 3:
Cleaved Caspase 3 (recombinant protein) at 0.1 µg
Secondary
All lanes:
800CW Goat Anti-Rabbit IgG at 1/10000 dilution
Predicted band size: 32 kDa
Observed band size: 17 kDa
false
関連する標識済み抗体及び組成の異なる製品 (1)
-
Anti-Cleaved Caspase-3 antibody [E83-77] - BSA and Azide free
Reactivity data
製品の詳細
Anti-Cleaved Caspase-3 antibody [E83-77] (ab32042) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in ICC/IF and WB.
Anti-Cleaved Caspase-3 antibody [E83-77] (ab32042) was first used in a scientific publication in 1994 and has been cited over 610 times in peer reviewed journals. It's performance in Western Blot in human samplesis trusted by the scientific community.
Abcam's high quality manufacturing and validation processes ensure Anti-Cleaved Caspase-3 antibody [E83-77] (ab32042) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility.
The specificity of Anti-Cleaved Caspase-3 antibody [E83-77] (ab32042) has been confirmed by Western Blot testing in Cleaved Caspase-3 knockout HAP1 cells.
Anti-Cleaved Caspase-3 antibody [E83-77] (ab32042) has 25 independent reviews from customers.
Anti-Cleaved Caspase-3 antibody [E83-77] (ab32042) specifically detects Cleaved Caspase-3 (UniProt ID: P42574; Molecular weight: 17kDa) and is sold in a convenient trial size to enable initial testing (20 µL) and larger sizes for subsequent scaling up experiments (100 µL and 1 mL).
Conjugation-ready, carrier free format available for antibody clone E83-77 - ab208003.
Cleaved Caspase-3 is a crucial marker of apoptosis, the programmed cell death process. It is the activated form of Caspase-3, resulting from proteolytic cleavage. Cleaved Caspase-3 plays a vital role in executing apoptosis by cleaving various cellular substrates, leading to cell dismantling. Researchers use Cleaved Caspase-3 as a reliable indicator of apoptosis in studies of cancer, neurodegenerative diseases and other conditions involving cell death. Its detection is essential for understanding the mechanisms of apoptosis and developing targeted therapies.
In cancer research, cleaved Caspase-3 is used to assess the effectiveness of anti-cancer therapies that induce apoptosis in tumor cells. Elevated levels of cleaved Caspase-3 have been associated with better prognosis in certain cancers, such as oral tongue squamous cell carcinoma. Additionally, cleaved Caspase-3 has been implicated in non-apoptotic roles, such as promoting angiogenesis and chemotherapy resistance.
Neurodegenerative Diseases: In neurodegenerative diseases like Alzheimer's (AD) and Parkinson's (PD) disease, cleaved Caspase-3 is involved in the apoptotic pathways that lead to neuronal cell death. For instance, caspase-3-cleaved Tau aggregates more easily than full-length Tau, contributing to the pathology of Alzheimer's disease.
Understanding the role of cleaved Caspase-3 in these diseases helps researchers develop targeted therapies to mitigate neuronal loss and disease progression.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Caspase 3 acts as an executioner enzyme in the process of programmed cell death. Its cleavage from the inactive zymogen form into the active form triggers apoptotic pathways ensuring the removal of damaged or unnecessary cells. Cleaved caspase operates within a proteolytic cascade often in conjunction with other caspases such as caspase 9. Once activated caspase 3 targets and cleaves specific cellular substrates contributing to the characteristic morphological changes and DNA fragmentation associated with apoptosis.
Pathways
Cleaved caspase 3 is significant within the intrinsic and extrinsic apoptotic pathways. It acts downstream of initiator caspases such as caspase 9 in the intrinsic pathway where its activation involves mitochondrial signals. In the extrinsic pathway it closely associates with caspase 8 mediating cell death signals from extracellular triggers. These pathways ensure that cleaved caspase 3 fulfills its role as a critical mediator of apoptosis linking upstream death signals to cellular dismantling during the apoptosis process.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (612)
Recent publications for all applications. Explore the full list and refine your search
PeerJ 11:e16593 PubMed38084140
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 14:7856 PubMed38030636
2023
Applications
Unspecified application
Species
Unspecified reactive species
Analytical cellular pathology (Amsterdam) 2023:1108280 PubMed38028435
2023
Applications
Unspecified application
Species
Unspecified reactive species
American journal of cancer research 13:5577-5589 PubMed38058835
2023
Applications
Unspecified application
Species
Unspecified reactive species
Signal transduction and targeted therapy 8:428 PubMed37963877
2023
Applications
Unspecified application
Species
Unspecified reactive species
Molecular and cellular biochemistry : PubMed37948019
2023
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 28: PubMed37921069
2023
Applications
Unspecified application
Species
Unspecified reactive species
Allergologia et immunopathologia 51:1-7 PubMed37937489
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 14:6905 PubMed37903795
2023
Applications
Unspecified application
Species
Unspecified reactive species
BMC complementary medicine and therapies 23:381 PubMed37891619
2023
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com